RocketVax
Series ABasel, SwitzerlandAug 2021
RocketVax raised €6.7M in a Series A round in Aug 2021. The company is based in Basel, Switzerland. Investors in the round: Canton of Basel-Stadt, Innosuisse, University Hospital Basel. Data as of Nov 2026.
Amount raised
€6.7M
€6,708,283
Native amount
7,200,000 CHF
Stage
Series A
series a
Investors
3
Provenance & confidence
High confidenceAmount
7,200,000 CHF
ECB-at-date → €6.7M · rate 1.0733 on 2021-08-05
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Aug 2021
Round type
series a
Amount (EUR)
€6.7M
Other rounds
same companyThis is the company's only recorded round.
Related news
- RocketVax raises CHF 7.2 million to advance clinical studies for its COVID 19 vaccinestartupticker.ch · 2021-08